Appropriate utilization of the prognostic 40-gene expression profile (40-GEP) test for cutaneous squamous cell carcinoma (cSCC) demonstrated by clinical reports and physician evaluation of real-world cases. J of Skin. 2022;6(2):s21. doi:10.25251/skin.6.supp.21